［1］ SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA-A Cancer Journal for Clinicians，2021,71(3):209-249.
［2］ TAN S,SCHUBERT D,MAHER P.Oxytosis:A novel form of programmed cell death ［J］.Current Topics in Medicinal Chemistry,2001,1(6):497-506.
［3］ DOLMA S,LESSNICK SL,HAHN WC,et al.Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells［J］.Cancer Cell,2003,3(3):285-296.
［4］ YANG WS,STOCKWELL BR.Synthetic lethal screening identifies compounds activating iron-dependent,nonapoptotic cell death in oncogenic-RAS-harboring cancer cells［J］.Chemistry & Biology,2008,15(3):234-245.
［5］ DIXON SJ,LEMBERG KM,LAMPRECHT MR,et al.Ferroptosis:an iron-dependent form of nonapoptotic cell death［J］.Cell,2012,149(5):1060-1072.
［6］ YANG WS,SRIRAMARATNAM R,WELSCH ME,et al.Regulation of ferroptotic cancer cell death by GPX4［J］.Cell,2014,156(1-2):317-331.
［7］ JIANG X,STOCKWELL BR,CONRAD M.Ferroptosis:mechanisms,biology and role in disease［J］.Nature Reviews Molecular Cell Biology,2021,22(4):266-282.
［8］ ANTHONYMUTHU TS,TYURUNA YY,SUN WY,et al.Resolving the paradox of ferroptotic cell death:Ferrostatin-1 binds to 15LOX/PEBP1 complex,suppresses generation of peroxidized ETE-PE,and protects against ferroptosis［J］.Redox Biology,2021,38:101744.
［9］ LEE JY,KIM WK,BAE KH,et al.Lipid metabolism and ferroptosis［J］.Biology,2021,10(3):184.
［10］ GAO M,MONNIAN P,QUADR N,et al.Glutaminolysis and transferrin regulate ferroptosis［J］.Molecular Cell,2015,59(2):298-308.
［11］ WANG Y,LIU Y,LIU J,et al.NEDD4L-mediated LTF protein degradation limits ferroptosis［J］.Biochemical and Biophysical Research Communications,2020,531(4):581-587.
［12］ HONG X,ROH W,SULLIVAN RJ,et al.The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis［J］.Cancer Discovery,2021,11(3):678-695.
［13］ GENG N,SHI BJ,LI SL,et al.Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells［J］.European Review for Medical and Pharmacological Sciences,2018,22(12):3826-3836.
［14］ BROWN CW,AMANTE JJ,CHHOY P,et al.Prominin2 drives ferroptosis resistance by stimulating iron export［J］.Developmental Cell,2019,51(5):575-586.
［15］ GAO M,MONIAN P,PAN Q,et al.Ferroptosis is an autophagic cell death process［J］.Cell Research,2016,26(9):1021-1032.
［16］ CHEN X,KANG R,KROEMER G,et al.Broadening horizons:the role of ferroptosis in cancer［J］.Nature Reviews Clinical Oncology,2021,18(5):280-296.
［17］ HONG T,LEI G,CHEN X,et al.PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer［J］.Redox Biology,2021,42:101928.
［18］ ZHANG X,SUI S,WANG L,et al.Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin［J］.Journal of Cellular Physiology,2020,235(4):3425-3437.
［19］ ZOU Y,PALTE MJ,DEIK AA,et al.A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis［J］.Nature Communications,2019,10(1):1617.
［20］ MIESS H,DANKWORTH B,GOUW AM,et al.The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma［J］.Oncogene,2018,37(40):5435-5450.
［21］ TAN SK,MAHMUD I,FONTANESI F,et al.Obesity-dependent adipokine chemerin suppresses fatty acid oxidation to confer ferroptosis resistance［J］.Cancer Discovery,2021,11(8):2072-2093.
［22］ GREEN YS,FERREIRA DOS SANTOS MC,FUJA DG,et al.ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma［J］.Oncogene,2022,41(42):4709-4723.
［23］ MORI M,TRIBOULET R,MOHSENI M,et al.Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer［J］.Cell,2014,156(5):893-906.
［24］ YANG WH,DING CC,SUN T,et al.The Hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma［J］.Cell Reports,2019,28(10):2501-2508.
［25］ XU CL,CHEN L,LI D,et al.Acyl-CoA thioesterase 8 and 11 as novel biomarkers for clear cell renal cell carcinoma［J］.Front Genet,2020,11:594969.
［26］ YANG WH,LIN CC,WU J,et al.The Hippo pathway effector YAP promotes ferroptosis via the E3 ligase SKP2［J］.Mol Cancer Res,2021,19(6):1005-1014.
［27］ ZHANG Y,LI Y,QIU Q,et al.MITD1 deficiency suppresses clear cell renal cell carcinoma growth and migration by inducing ferroptosis through the TAZ/SLC7A11 pathway［J］.Oxid Med Cell Longev,2022,2022:7560569.
［28］ MOU Y,WU J,ZHANG Y,et al.Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma［J］.BMC Cancer,2021,21(1):18.
［29］ WANG J,YIN X,HE W,et al.SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis［J］.Acta Pharm Sin B,2021,11(2):406-419.
［30］LI Y,ZHANG Y,QIU Q,et al.Energy-stress-mediated AMPK activation promotes GPX4-dependent ferroptosis through the JAK2/STAT3/P53 axis in renal cancer［J］.Oxid Med Cell Longev,2022,2022:2353115.
［31］ LEE H,ZANDKARIMI F,ZHANG Y,et al.Energy-stress-mediated AMPK activation inhibits ferroptosis［J］.Nat Cell Biol,2020,22(2):225-234.
［32］ MARKOWITSCH SD,SCHUPP P,LAUCKNER J,et al.Artesunate inhibits growth of sunitinib-resistant renal cell carcinoma cells through cell cycle arrest and induction of ferroptosis［J］.Cancers (Basel),2020,12(11):3150.
［33］ WANG YY,SHI GW,SHI SF,et al.Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma［J］.Gene,2022,809:145992.
［34］ NI W,LI Y,LIANG L,et al.Tumor microenvironment-responsive nanodrug for clear-cell renal cell carcinoma therapy via triggering waterfall-like cascade ferroptosis［J］.J Biomed Nanotechnol,2022,18(2):327-342.
［35］ YI J,ZHU J,WU J,et al.Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis［J］.Proceedings of the National Academy of Sciences of the United States of America,2020,117(49):31189-31197.
［36］ NASSAR ZD,MAH CY,DEHAIRS J,et al.Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis［J］.Elife,2020,9:e54166.
［37］ BLOMME A,FORD CA,MUI E,et al.2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer［J］.Nature Communications,2020,11(1):2508.
［38］ GHOOCHANI A,HSU EC,ASLAN M,et al.Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer［J］.Cancer Research,2021,81(6):1583-1594.
［39］ TOUSIGNANT KD,ROCKSTROH A,POAD BLJ,et al.Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer［J］.Cancer Metabolism,2020,8:11.
［40］ YANG Y,LIU T,HU C,et al.Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration resistant prostate cancer［J］.Oncology Reports,2021,45(4):25.
［41］ KIM KS,CHOI B,CHOI H,et al.Enhanced natural killer cell ant-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer［J］.Nanobiotechnology,2022,20(1):428.
［42］ GUO P,WANG L,SHANG W,et al.Intravesical in situ immunostimulatory gel for triple therapy of bladder cancer［J］.ACS Applied Materials & Interfaces,2020,12(49):54367-54377.
［43］ QI A,WANG C,NI S,et al.Intravesical mucoadhesive hydrogel induces chemoresistant bladder cancer ferroptosis through delivering iron oxide nanoparticles in a three-tier strategy［J］.ACS Applied Materials & Interfaces,2021,13:52374-52384.
［44］ JASIM KA,GESQUIERE AJ.Ultrastable and biofunctionalizable conjugated polymer nanoparticles with encapsulated iron for ferroptosis assisted chemodynamic therapy［J］.Molecular Pharmaceutics,2019,16(12):4852-4866.